These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37188121)

  • 1. Long-term assist device patients admitted to ICU: Tips and pitfalls.
    Morshuis M; Fox H; Lauenroth V; Schramm R
    J Intensive Med; 2023 Apr; 3(2):81-88. PubMed ID: 37188121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate 3™.
    Hanke JS; Mariani S; Merzah AS; Bounader K; Li T; Haverich A; Schmitto JD; Dogan G
    J Cardiovasc Surg (Torino); 2021 Dec; 62(6):646-651. PubMed ID: 34057162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.
    Hanke JS; Rojas SV; Cvitkovic T; Wiegmann B; Horke A; Warnecke G; Haverich A; Schmitto JD
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):503-508. PubMed ID: 28962493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
    Mehra MR; Crandall DL; Gustafsson F; Jorde UP; Katz JN; Netuka I; Uriel N; Connors JM; Sood P; Heatley G; Pagani FD
    Eur J Heart Fail; 2021 Jul; 23(7):1226-1237. PubMed ID: 34142415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
    Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
    Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
    ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.
    Tsiouris A; Paone G; Nemeh HW; Borgi J; Williams CT; Lanfear DE; Morgan JA
    World J Cardiol; 2015 Nov; 7(11):792-800. PubMed ID: 26635927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical circulatory support devices as destination therapy-current evidence.
    Puehler T; Ensminger S; Schoenbrodt M; Börgermann J; Rehn E; Hakim-Meibodi K; Morshuis M; Gummert J
    Ann Cardiothorac Surg; 2014 Sep; 3(5):513-24. PubMed ID: 25452913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
    McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
    Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.